Performance of BGNE BeiGene | -28.4% in 12m
Compare BGNE with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare BeiGene with its related Sector/Index XBI
Performance Duell BGNE vs XBI
| TimeFrame | BGNE | XBI |
|---|---|---|
| 1 Day | 3.73% | -0.02% |
| 1 Week | 1.42% | 4.06% |
| 1 Month | 27.6% | 8.15% |
| 3 Months | 15.4% | -0.60% |
| 6 Months | -9.59% | 32.05% |
| 12 Months | -28.4% | 8.91% |
| YTD | -3.37% | 2.62% |
| Rel. Perf. 1m | 1.45 | |
| Rel. Perf. 3m | -1.05 | |
| Rel. Perf. 6m | -4.62 | |
| Rel. Perf. 12m | -4.10 |
Is BeiGene a good stock to buy?
No, based on ValueRay Fundamental Analyses, BeiGene (NASDAQ:BGNE) is currently (May 2024)
a stock to sell. It has a ValueRay Fundamental Rating of -50.45 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BGNE as of May 2024 is 148.84. This means that BGNE is currently overvalued and has a potential downside of -12.97% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BGNE as of May 2024 is 148.84. This means that BGNE is currently overvalued and has a potential downside of -12.97% (Sold with Premium).
Is BGNE a buy, sell or hold?
- Strong Buy: 14
- Buy: 5
- Hold: 2
- Sell: 0
- Strong Sell: 0
Values above 0%: BGNE is performing better - Values below 0%: BGNE is underperforming
Compare BGNE with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -0.22% | 22.59% | -27.86% | -59.15% |
| US NASDAQ 100 | QQQ | -1.07% | 22.75% | -27.15% | -67.49% |
| US Dow Jones Industrial 30 | DIA | 0.10% | 21.86% | -24.71% | -51.59% |
| German DAX 40 | DBXD | 1.25% | 22.41% | -27.79% | -45.70% |
| UK FTSE 100 | ISFU | -0.64% | 17.11% | -27.79% | -43.11% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 2.41% | 23.00% | -12.44% | -18.56% |
| Hongkong Hang Seng | HSI | -3.09% | 5.98% | -13.82% | -20.92% |
| Japan Nikkei 225 | EXX7 | 0.81% | 29.42% | -22.58% | -42.07% |
| India NIFTY 50 | INDA | -0.44% | 24.89% | -26.38% | -55.87% |
| Brasil Bovespa | EWZ | 1.89% | 22.20% | -7.08% | -42.16% |
BGNE BeiGene vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 0.44% | 24.54% | -27.88% | -67.33% |
| Consumer Discretionary | XLY | 2.13% | 24.92% | -17.10% | -49.95% |
| Consumer Staples | XLP | -0.16% | 20.35% | -23.96% | -34.20% |
| Energy | XLE | 2.16% | 28.38% | -24.50% | -54.27% |
| Financial | XLF | 0.20% | 21.05% | -31.75% | -63.16% |
| Health Care | XLV | -0.49% | 22.29% | -24.14% | -41.84% |
| Industrial | XLI | 1.74% | 24.76% | -29.91% | -58.80% |
| Materials | XLB | 1.81% | 24.70% | -24.84% | -48.79% |
| Real Estate | XLRE | -0.71% | 20.01% | -19.11% | -39.83% |
| Technology | XLK | -2.25% | 22.37% | -25.93% | -68.88% |
| Utilities | XLU | 0.10% | 12.44% | -28.01% | -40.59% |
| Aerospace & Defense | XAR | 1.02% | 20.06% | -25.50% | -55.36% |
| Biotech | XBI | -2.64% | 19.44% | -41.64% | -37.32% |
| Homebuilder | XHB | 1.95% | 22.21% | -41.31% | -81.46% |
| Retail | XRT | -0.95% | 19.76% | -34.77% | -58.13% |
Does BeiGene outperform its market, is BGNE a Sector Leader?
No, over the last 12 months BeiGene (BGNE) made -28.41%, while its related Sector, the SPDR S&P Biotech (XBI) made 8.91%.
Over the last 3 months BGNE made 15.38%, while XBI made -0.60%.
No, over the last 12 months BeiGene (BGNE) made -28.41%, while its related Sector, the SPDR S&P Biotech (XBI) made 8.91%.
Over the last 3 months BGNE made 15.38%, while XBI made -0.60%.
| Period | BGNE | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 27.59% | 8.15% | 5.00% |
| 3 Months | 15.38% | -0.60% | 6.17% |
| 12 Months | -28.41% | 8.91% | 30.74% |